Document -
Scotland first in the UK to make VENCLYXTO®▼ (venetoclax) routinely available for patients with most common form of adult leukaemia
Scottish Medicines Consortium accepts AbbVie’s venetoclax for routine prescribing across NHS Scotland, offering a new therapy option for patients with certain types of difficult-to-treat chronic lymphocytic Leukemia (CLL).
- License:
- All rights reserved
The Content may only be used by Mynewsdesk. It is thus not permissible for anyone else to download, copy, distribute or otherwise use the Content (other than for private use to the extent permitted by law).
- File format: